Scientists track families to unlock secrets of inherited kidney cancer

NCT ID NCT00001238

First seen Jun 26, 2026 · Last updated Aug 14, 2026 · Updated 6 times

Summary

This study follows families with a history of inherited kidney cancer to learn more about the disease's genetic causes and how it progresses. Researchers will collect blood, tissue, and urine samples from affected individuals and their relatives. The goal is to identify new genes linked to these cancers and improve future diagnosis and management. No experimental treatments are being tested.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this could lead to better understanding of inherited kidney cancers and help identify new genetic targets for future treatments.
What could go wrong
This is an observational study, not a treatment trial. It may not directly benefit participants, and results may take many years to translate into therapies.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BIRT-HOGG-DUBÉ SYNDROME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • National Institutes of Health Clinical Center

    RECRUITING

    Bethesda, Maryland, 20892, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.